References
- AMA American Medical Association. — Drug Evaluations, 2nd edition. Publishing Sciences Group, Acton, Massachusetts 1973; 25–30
- Axelrod J., Shofer R., Inscoe J. K., King W. M., Sjoerdsma A. J. Pharmac. exp. Ther. 1958; 124: 9
- Belpaire F. M., Bogaert M. G. Biochem. Pharmac 1973a; 22: 59
- Belpaire F. M., Bogaert M. G. Arch. int. Pharmacodyn. Ther. 1973b; 203: 388
- Belpaire F. M., Bogaert M. G. Arch. int. Pharmacodyn. Ther. 1974; 208: 362
- Belpaire F. M., Bogaert M. G., Rosseel M. T., Anteuxis M. Xenobiotica 1975; 5: 413
- Belpaire F. M., Bogaert M. G. Xenobiotica 1975a; 5: 421
- Belpaire F. M., Bogaert M. G. Xenobiotica 1975b; 5: 431
- Bobbitt J. M. Thin Layer Chromatography. Reinhold, New York 1963; 93
- Brochmann-Haxssen E., Hirai K. J. pharm. Set. 1968; 57: 940
- Brossi A., Teitel S. J. org. Chem. 1970; 35: 1684
- Duvoisin R. C. J. Am. med. Assoc 1975; 231: 845
- Erhardt P. W., Smith R. V., Sayther T. T., Reiser J. E. J. Chromatozr. 1976; 116: 218
- Hanna P. E., O'Dea R. F., Goldberg N. D. Biochem. Pharmac 1972; 21: 2266
- Kato R., Jondorf W., Loeb L., Ben T., Gelboin H. Molec. Pharmac 1966; 2: 171
- Kiaer H. W., Olsen S., Ronnov-Jessen V. Arch. Path. 1974; 98: 292
- Lewis A. J. Modern Drug Encyclopedia, 12th edition. Yorke Medical Group, New York 1973; 551–552
- National Prescription Audit, General Information Report, 10th edition. R. A. Gosselin and Co., Dedham, Massachusetts 1971
- Rosazza J. P., Smith R. V., Stocklinski A. W., Gustafsox M. E., Adrian J. J. med. Chem. 1975; 18: 791
- Smith R. V., Rosazza J. P. Arch. Biochem. Biophys. 1974; 161: 551
- Smith R. V., Rosazza J. P. J. pharm. Sci. 1975; 64: 1737
- U.S. Dept. H.E.W., Washington, D.C. 1968, United States Dept. of Health, Education & Welfare, The Drug Users, Task Force on Prescription Drugs, Background Papers